It takes both to meet your compounding needs
What is the difference between 503A and 503B compounding?
503A compounding complies with USP <797> standards and focuses on customized patient-specific compounding dispensed only with a prescription. CAPS is the market leader in customized Parenteral Nutrition and has the largest network of 503A regional facilities (22) in the industry. CAPS also offers patient-specific chemotherapy and hydration from our regional 503A pharmacies for daily delivery.
503B compounding is essentially batch compounding with required compliance to the federal cGMP regulations including 100% release testing quality assurance. These facilities comply with GMP level standards.
|Follows quality standards for USP <797>||Complies with cGMP regulations. Conducts 100% release testing on drug batches|
|Customized services with local delivery for patient-specific needs||Non-patient specific, with beyond use dating|
|Patient-specific labels with barcoding, ISMP-safe labeling features||503B label standards with barcoding, ISMP-safe labeling features|
|Easy online ordering with CAPSlink||Easy online ordering with CAPSlink|
|Over two decades of experience||Transparent reporting on quality and customer service|
|Delivering solutions every day||Delivering confidence every day|
CAPS offers 22 503A regional pharmacies registered to dispense your customized, patient-specific compounding needs.
- Parenteral Nutrition (PN)
- Patient-Specific drug doses
- (IVPB, Syringe, CRRT)
CAPS offers two 503B outsourcing facilities registered with the FDA to dispense non-patient-specific CSPs.
- Anesthesia Syringes
- Drug delivery
- Neonatal PN Starter Bags
- Controlled Substances